XML 18 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2020
Revenue:      
Total revenue $ 99,951 $ 105,136 $ 94,864
Operating costs and expenses:      
Cost, Product and Service [Extensible Enumeration] Product Sales [Member] Product Sales [Member] Product Sales [Member]
Product costs $ 20,342 $ 17,177 $ 15,317
Research and development 50,609 46,734 50,188
Selling, general and administrative 46,935 30,677 28,392
Acquired intangible asset amortization 4,150 2,793 2,218
Acquisition transaction, integration and other costs   1,049  
Contingent consideration expense 12 3  
Total operating costs and expenses 122,048 98,433 96,115
Operating (loss) income (22,097) 6,703 (1,251)
Other expense:      
Interest expense (598) (310) (133)
Foreign exchange gain (loss) 103 (170) (248)
Investment income, net 99 123 656
Loss on strategic investments and other     (478)
Other expense (396) (357) (203)
(Loss) income before income taxes (22,493) 6,346 (1,454)
Income tax (provision) benefit (4,781) (2,109) 2,577
Net (loss) income $ (27,274) $ 4,237 $ 1,123
Basic net (loss) income per share $ (1.96) $ 0.31 $ 0.08
Diluted net (loss) income per share $ (1.96) $ 0.30 $ 0.08
Weighted average number of shares outstanding:      
Basic 13,916 13,765 13,552
Diluted 13,916 13,989 13,812
Product Sales [Member]      
Revenue:      
Total revenue $ 54,621 $ 46,478 $ 44,317
Royalties and License Fees [Member]      
Revenue:      
Total revenue 36,248 47,056 40,634
Research, Development and Other [Member]      
Revenue:      
Total revenue $ 9,082 $ 11,602 $ 9,913